Chlorhexidine Mouthwash and Bacterial Contamination During Endoscopy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01154530|
Recruitment Status : Completed
First Posted : July 1, 2010
Last Update Posted : August 17, 2011
Natural Orifice Transluminal Endoscopic Surgery (NOTES) is a surgical technique that has been rapidly evolving over the last five years. The technique probably has a great potential in surgical gastroenterology, urology and gynaecology.
The technique is based on the idea of minimally invasive surgery. The human organism is affected by a stress response when exposed to surgery. This stress response can be minimized by reducing the size of the openings whereby the surgeon gains access to the organs. This affects how quickly a patient recovers after surgery and can be discharged and resumes daily life and work. The same principal have been responsible for the surgical evolution in the last 15-20 years where many procedures have gone from traditional open operations with large incisions in the abdominal wall to laparoscopic surgery with cameras through small holes in the abdominal wall.
The latest addition to minimal invasive surgery is NOTES. Here the surgeon gains access to the abdominal organs with flexible endoscopes through the body's natural openings i.e. the mouth and stomach. With this technique the surgeon avoids cutting through skin and muscle of the abdominal wall, thus minimizing the surgical stress response. This minimizes postoperative pain, the incidence of incisional hernias, eliminates wound infection, and properly prevents scar tissue formation inside the abdominal cavity which way lead to ileus. The end result is a quicker discharge and a better cosmetic result.
It has been shown in numerous animal studies that NOTES is feasible and in recent years a rapidly increasing number of published patient series.
However, there is a risk of infection associated with accessing the abdominal cavity through a natural body opening, which initially is unclean and can not be disinfected in the same way as the skin of the abdominal wall.
Numerous microbiological pig studies have shown that there is transfer of bacteria from the body opening (i.e. mouth) to the abdominal cavity when performing NOTES, but this contamination have no correlation to infection after surgery, neither in terms of healing or survival.
It is unclear from the literature whether patients should be offered proton pump inhibitor (PPI) therapy to reduce the acidity of the stomach before NOTES interventions. The rationale has been that such a treatment can make the gastric juices less acidic and thereby reduce the incidence of chemical peritonitis, which can occur when acidic juices flows from the stomach and into the abdominal cavity. It is known however that the acidic environment of the stomach provides a natural barrier for bacteria. Making the gastric juices less acidic could potentially increase the risk of bacterial peritonitis.
It is known that the bacterial content of the stomach is low due the acidic environment but bacteria passed down from the mouth and throat with the endoscope could potentially result in bacterial peritonitis.
That bacteria from the throat can lead to infections due to instrumentation is known from intensive care units. Ventilated patients may risk getting pneumonia with bacteria from the throat. Several studies have shown that using mouthwash with a chlorhexidine solution can reduce the risk of ventilator associated pneumonia.
Mouthwash with 2 cl 0,2% chlorhexidine solution before a gastroscopy reduces the bacterial content in cultures taken from the stomach and the endoscope after a gastroscopy.
Simultaneous PPI treatment gives higher bacterial counts in the cultures.
|Condition or disease||Intervention/treatment||Phase|
|Gastroscopy||Other: Chlorhexidine||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||102 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Chlorhexidine Mouthwash and Bacterial Contamination During Endoscopy. Implementation of Chlorhexidine Mouthwash Before Transgastric NOTES|
|Study Start Date :||January 2011|
|Actual Primary Completion Date :||August 2011|
|Actual Study Completion Date :||August 2011|
Active Comparator: Chlorhexidine mouthwash
Participants randomized to chlorhexidine mouthwash prior to gastroscopy
Mouthwash with a 0,2 % chlorhexidine solution for 30 seconds
No Intervention: No mouthwash
Mouthwash is not performed prior to gastroscopy as is the standard today.
- Quantification of culture samples [ Time Frame: 1 week ]Bacterial count in the culture samples. Quantified with colony forming units (CFU).
- The influence of PPI treatment on bacterial count [ Time Frame: 1 week ]To study whether ongoing PPI treatment gives higher bacterial counts in the culture samples
- Bacteria species [ Time Frame: 1 week ]Classification of bacteria species in the culture samples
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01154530
|Herlev Hospital, Department of surgical gastroenterology|
|Herlev, Denmark, 2730|
|Principal Investigator:||Anders Meller Donatsky, MD||Herlev Hospital, Department of surgical gastroenterology|
|Study Director:||Jacob Rosenberg, MD DSc Prof||Herlev Hospital, Department of surgical gastroenterology|
|Study Director:||Søren Meisner, MD||Bispebjerg Hospital, Department of surgical gastroenterology|
|Study Director:||Lars Nannestad Jørgensen, MD DSc prof||Bispebjerg Hospital, Department of surgical gastroenterology|
|Study Director:||Peter Vilmann, MD DSc Prof||Gentofte Hospital, Department of surgical gastroenterology|